Green tea polyphenols in the prevention of colon cancer

Nagi Kumar1, David Shibata, James Helm

  • 1Division of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida College of Medicine, Tampa, Florida 33612, USA. kumar@moffitt.usf.edu

Insights

Green tea polyphenols (GTP), particularly epigallocatechin gallate (EGCG), show promise as natural chemopreventive agents for colon cancer. These compounds inhibit cancer cell growth and proliferation with low toxicity, offering a safe dietary alternative.

Area of Science:

  • Oncology
  • Nutritional Science
  • Chemoprevention

Background:

  • Plant-derived compounds like Green Tea Polyphenols (GTP) are investigated for cancer prevention.
  • Key compounds such as epigallocatechin gallate (EGCG) demonstrate anti-mutagenic and anti-proliferative properties.
  • These agents are considered for colon cancer prevention due to their safety and dietary accessibility.

Purpose of the Study:

  • To review the rationale and evidence for using EGCG from GTP as a chemopreventive agent for colon cancer.
  • To evaluate the efficacy and safety of EGCG in colon cancer prevention.
  • To present findings from epidemiological, animal, in vitro, and Phase I clinical studies.

Main Methods:

  • Review of epidemiological data linking diet and colon cancer.
  • Analysis of in vitro studies on cancer cell lines.
  • Examination of animal models of colon carcinogenesis.
  • Evaluation of Phase I clinical trial data on EGCG safety and efficacy.

Main Results:

  • EGCG is identified as a potent chemopreventive agent within GTP.
  • EGCG demonstrates the ability to induce apoptosis and suppress tumor formation and growth.
  • Evidence suggests EGCG is effective against colorectal cancers (CRC).

Conclusions:

  • EGCG in GTP is a promising chemopreventive agent for colon cancer.
  • Phytochemicals like EGCG offer a viable alternative to pharmacological agents, especially when NSAIDs are contraindicated.
  • Further clinical studies are warranted to confirm the efficacy and safety of EGCG for colon cancer prevention.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...